What is IPO GMP? Grey Market Premium — Complete Guide 2026

What is IPO GMP (Grey Market Premium)?

Grey Market Premium (GMP) is the premium amount at which IPO shares change hands in the informal grey market before the company officially lists on NSE or BSE. This unofficial market operates outside SEBI's regulatory framework and is most active in cities like Jaipur, Ahmedabad, Surat, and Delhi where grey market operators are concentrated.

When a company files its DRHP or announces IPO dates, grey market participants begin buying and selling the right to those IPO shares informally. The price at which these transactions happen — minus the issue price — is the GMP. A positive GMP indicates market optimism about the stock; a zero or negative GMP signals skepticism.

How to Read GMP Data

GMP is displayed as an absolute number (in rupees) and as a percentage of the issue price:

• +₹50 GMP (10%) — Grey market expects listing 10% above issue price. Positive signal.
• ₹0 GMP (0%) — Market is neutral; no significant premium or discount expected.
• -₹20 GMP (-4%) — Grey market expects listing below issue price. Bearish signal.

A high and rising GMP in the days leading up to listing is typically the strongest bullish signal. A falling GMP in the final days before listing — even if still positive — may indicate that initial enthusiasm is waning.

What is Kostak Rate?

Kostak (also written as Kostak Rate) is the price paid in the grey market for an entire IPO application, regardless of whether that application receives allotment or not. This is fundamentally different from GMP:

• GMP applies per share — it reflects expected listing gains on each share allotted.
• Kostak applies per application — the buyer pays a fixed amount for the entire application and takes on all allotment risk.

Example: If an IPO has a Kostak rate of ₹2,000 and you applied for the minimum retail lot (1 application), you can sell your entire application for ₹2,000 to a grey market operator. Whether or not you get allotted, you receive ₹2,000. The buyer receives the allotted shares (if any) and bears the full allotment risk.

What is Subject to Sauda (Sub-To)?

Subject to Sauda (abbreviated "Sub-To") is a grey market arrangement where the transaction is conditional on allotment. Unlike Kostak, money exchanges hands only if the seller receives allotment. The seller is paid a fixed amount per share for every share allotted — nothing is paid if no allotment occurs.

This aligns incentives differently from Kostak — the buyer only pays for actual shares received. Sub-To rates are usually higher than Kostak rates on a per-share basis because the buyer bears the risk of receiving fewer shares than expected in heavily oversubscribed IPOs.

Is GMP Reliable? Can You Trust It?

GMP has historically shown a reasonable correlation with actual listing prices for large, well-known IPOs with high institutional subscription. However, GMP has several significant limitations:

• Manipulation risk: Vested interests (promoters, operators) can artificially inflate GMP to generate retail enthusiasm before an IPO closes.
• Rapid changes: GMP can swing dramatically in 24-48 hours before listing based on market sentiment shifts.
• Small IPO unreliability: For SME IPOs with low liquidity, GMP can be completely misleading due to thin trading volumes in the grey market itself.
• Market condition dependence: A good GMP in bullish markets means little if market conditions deteriorate before listing day.

IPOGenie's approach: Use GMP as one of many signals, not as a primary investment trigger. Always evaluate the company's fundamentals, financial performance, sector outlook, and valuation alongside GMP data.

GMP vs Actual Listing — Historical Accuracy

In general, for mainboard IPOs subscribed more than 20x overall with QIB subscription above 10x, GMP has been a reasonable predictor (within 5-10%) of listing price direction. For SME IPOs, the accuracy drops significantly. For weakly subscribed IPOs, GMP is often wildly optimistic due to low trading volumes in the grey market.

Legal Status of GMP Trading

Grey market trading of IPO shares is technically not regulated under Indian securities law — there are no specific laws making it illegal, but it also has no legal protection. Disputes arising from grey market transactions have no legal remedy. SEBI and exchanges have no jurisdiction over grey market operators. All grey market transactions carry significant counterparty risk.

IPOGenie displays GMP data for informational purposes only and does not endorse, facilitate, or encourage participation in grey market trading.